What antibiotics are recommended for treating peritonitis in an adult patient on peritoneal dialysis?

Empirical Antibiotic Therapy for Peritoneal Dialysis-Associated Peritonitis

For peritoneal dialysis-associated peritonitis, initiate empirical therapy with intraperitoneal vancomycin (or a first-generation cephalosporin if MRSA prevalence is low) PLUS a third-generation cephalosporin with anti-pseudomonal coverage (ceftazidime) or an aminoglycoside (gentamicin). This dual-agent approach provides broad coverage against both Gram-positive organisms (predominantly staphylococci) and Gram-negative bacteria (including Pseudomonas species) that commonly cause PD peritonitis 1.

Recommended Empirical Regimens

The evidence strongly supports intraperitoneal administration as the preferred route for antibiotic delivery in PD peritonitis 1, 2. Choose one of these combinations:

Primary Recommendation

• Vancomycin (intraperitoneal) PLUS Ceftazidime (intraperitoneal)
  • This combination shows superior resolution rates (86%) compared to other regimens 2
  • Provides optimal coverage for both Gram-positive organisms and Pseudomonas species

Alternative Regimens

• Vancomycin PLUS Gentamicin (both intraperitoneal)

  • Widely used with sustained efficacy and low resistance rates (vancomycin resistance ~2%, gentamicin resistance ~8%) 3
  • Particularly appropriate when local antibiogram data supports this combination

• First-generation cephalosporin (e.g., cefazolin) PLUS aminoglycoside

  • Reserve for centers with documented low MRSA prevalence (<10%)
  • Shows lower resolution rates (66%) compared to glycopeptide-based regimens 2

Critical Implementation Details

Dosing Considerations

While specific intraperitoneal dosing should follow ISPD guidelines, key principles include:

• Loading doses in the first exchange to achieve rapid therapeutic levels
• Maintenance doses in subsequent exchanges
• Continuous dosing (antibiotics in every exchange) is generally preferred over intermittent dosing

Adjunctive Therapy

Add antifungal prophylaxis (preferably oral nystatin) immediately when starting antibiotics to prevent secondary fungal peritonitis 1. This is a critical but often overlooked component of initial management.

Microbiologic Sampling

Before initiating antibiotics:

• Obtain PD effluent for cell count, Gram stain, and culture
• Inoculate fluid directly into blood culture bottles rather than using swabs or solid media alone—this significantly improves organism recovery rates 4
• Send adequate volume per manufacturer specifications

Tailoring Therapy Based on Culture Results

Gram-Positive Coverage

Once cultures identify Gram-positive organisms:

• Methicillin-susceptible staphylococci: Switch to cefazolin (preferred over vancomycin)
• MRSA or vancomycin-resistant organisms: Continue vancomycin; if non-susceptible or allergic, use linezolid (oral or IV) or daptomycin (IV or intraperitoneal) 5
• Both linezolid and daptomycin show excellent efficacy for drug-resistant Gram-positive peritonitis

Gram-Negative Coverage

For confirmed Gram-negative organisms:

• Continue ceftazidime for Pseudomonas coverage
• Adjust based on susceptibilities
• Extended-spectrum beta-lactamase (ESBL) producers: Consider carbapenems; polymyxins may be necessary for highly resistant organisms, though evidence is limited 5, 6

Culture-Negative Peritonitis

If cultures remain negative after 48-72 hours but clinical improvement occurs:

• Continue empirical dual therapy
• Standard treatment duration applies

Treatment Duration

Standard duration is 2-3 weeks depending on the organism identified 1:

• Most Gram-positive infections: 2 weeks
• Gram-negative infections (especially Pseudomonas): 3 weeks
• Adjust based on clinical response and organism-specific recommendations

When to Remove the Catheter

Immediate catheter removal is indicated for:

• Refractory peritonitis (no clinical improvement after 5 days of appropriate antibiotics)
• Relapsing peritonitis (same organism within 4 weeks)
• Fungal peritonitis (remove catheter immediately upon identification)
• Refractory exit site or tunnel infections 1

Temporary hemodialysis support will be necessary. A new PD catheter may be inserted after complete resolution of infection in selected patients.

Common Pitfalls to Avoid

1. Delaying empirical therapy: Start antibiotics immediately after obtaining cultures—do not wait for results
2. Using oral antibiotics initially: Intraperitoneal route is superior for initial therapy; oral agents (like fluoroquinolones) may be considered only for uncomplicated cases without vomiting, ileus, or shock 7
3. Omitting antifungal prophylaxis: This significantly increases risk of secondary fungal peritonitis
4. Inadequate culture technique: Using swabs instead of fluid inoculation into blood culture bottles reduces organism recovery
5. Ignoring local resistance patterns: Quinolone resistance is increasing (up to 32% in some centers); adjust empirical choices accordingly 7, 6
6. Premature catheter removal: Allow 5 days of appropriate therapy before declaring treatment failure

Monitoring Response

Assess clinical response within 48-72 hours:

• Repeat cell count from PD effluent
• Expect decreasing white blood cell count and improving symptoms
• Adjust antibiotics based on culture and susceptibility results
• If no improvement by day 5 with appropriate antibiotics, consider catheter removal

The key to successful outcomes is rapid initiation of appropriate empirical therapy, proper culture technique, and early recognition of treatment failure requiring catheter removal.